Cogent Biosciences (COGT) EBT: 2017-2020
Historic EBT for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$82.1 million.
- Cogent Biosciences' EBT fell 594.78% to -$11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.1 million, marking a year-over-year decrease of 157.14%. This contributed to the annual value of -$82.1 million for FY2020, which is 157.14% down from last year.
- As of FY2020, Cogent Biosciences' EBT stood at -$82.1 million, which was down 157.14% from -$31.9 million recorded in FY2019.
- Over the past 5 years, Cogent Biosciences' EBT peaked at -$25.8 million during FY2017, and registered a low of -$82.1 million during FY2020.
- For the 3-year period, Cogent Biosciences' EBT averaged around -$49.6 million, with its median value being -$34.9 million (2018).
- Its EBT has fluctuated over the past 5 years, first climbed by 8.44% in 2019, then slumped by 157.14% in 2020.
- Cogent Biosciences' EBT (Yearly) stood at -$25.8 million in 2017, then tumbled by 35.26% to -$34.9 million in 2018, then rose by 8.44% to -$31.9 million in 2019, then plummeted by 157.14% to -$82.1 million in 2020.